Focused Alpha’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.22M Buy
4,657
+2,429
+109% +$623K 0.3% 56
2026
Q2
$561K Buy
2,228
+573
+35% +$123K 0.14% 142
2026
Q1
$360K Sell
1,655
-90
-5% -$20K 0.11% 181
2025
Q4
$399K Buy
+1,745
New +$398K 0.12% 167

Other funds holding ABBV

Focused Alpha's ABBV Position: Q3 2026 in Review

Focused Alpha increased its AbbVie (ABBV) stake by 109% in Q3 2026, buying an estimated $623K and bringing the position to 4,657 shares worth $1.22M. The position accounts for 0.3% of the portfolio, ranked #56.

Focused Alpha first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Focused Alpha held 4,657 shares of AbbVie worth $1.22M as of Q3 2026.
  • Focused Alpha bought 2,429 AbbVie shares in Q3 2026, an estimated $623K.
  • AbbVie made up 0.3% of Focused Alpha's portfolio in Q3 2026, its #56 holding.
  • Focused Alpha first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.